2901 related articles for article (PubMed ID: 7654000)
1. Cellular genes possibly involved in the transformation process of the human melanoma cell line XP44 RO (Mel).
Lafarge-Frayssinet C; Daya-Grosjean L; Estrade S; Frezouls G; Sarasin A; Cassingena R
Anticancer Res; 1995; 15(4):1205-13. PubMed ID: 7654000
[TBL] [Abstract][Full Text] [Related]
2. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
3. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.
Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M
Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463
[TBL] [Abstract][Full Text] [Related]
4. Resistance to retransformation by adenovirus but not by heterologous oncogenes in an E1-positive transformation revertant cell line may be mediated by a cellular function.
Sircar S; Rodrigues M; Weber JM
Oncogene; 1988 Dec; 3(6):725-8. PubMed ID: 2577877
[TBL] [Abstract][Full Text] [Related]
5. Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene.
Castelli C; Sensi M; Lupetti R; Mortarini R; Panceri P; Anichini A; Parmiani G
Cancer Res; 1994 Sep; 54(17):4785-90. PubMed ID: 8062279
[TBL] [Abstract][Full Text] [Related]
6. Activation of tumor suppressor genes in nontumorigenic revertants of the HeLa cervical carcinoma cell line.
Boylan MO; Athanassiou M; Houle B; Wang Y; Zarbl H
Cell Growth Differ; 1996 Jun; 7(6):725-35. PubMed ID: 8780886
[TBL] [Abstract][Full Text] [Related]
7. Increased radiation resistance in transformed and nontransformed cells with elevated ras proto-oncogene expression.
Samid D; Miller AC; Rimoldi D; Gafner J; Clark EP
Radiat Res; 1991 May; 126(2):244-50. PubMed ID: 2023995
[TBL] [Abstract][Full Text] [Related]
8. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
[TBL] [Abstract][Full Text] [Related]
9. Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay.
Raybaud F; Noguchi T; Marics I; Adelaide J; Planche J; Batoz M; Aubert C; de Lapeyriere O; Birnbaum D
Cancer Res; 1988 Feb; 48(4):950-3. PubMed ID: 3276402
[TBL] [Abstract][Full Text] [Related]
10. Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis.
Mello ML; Contente S; Vidal BC; Planding W; Schenck U
Exp Cell Res; 1995 Oct; 220(2):374-82. PubMed ID: 7556446
[TBL] [Abstract][Full Text] [Related]
11. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
Kivinen L; Pitkänen K; Laiho M
Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
[TBL] [Abstract][Full Text] [Related]
12. Isolation of a new class of 'flat' revertants from ras-transformed NIH3T3 cells using cis-4-hydroxy-L-proline.
Yanagihara K; Ciardiello F; Talbot N; McGeady ML; Cooper H; Benade L; Salomon DS; Bassin RH
Oncogene; 1990 Aug; 5(8):1179-86. PubMed ID: 2202950
[TBL] [Abstract][Full Text] [Related]
13. [Genetic bases of cutaneous tumors].
Basset-Séguin N; Dereure O; Guillot B
Ann Dermatol Venereol; 1995; 122(4):217-25. PubMed ID: 8526416
[TBL] [Abstract][Full Text] [Related]
14. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ
Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993
[TBL] [Abstract][Full Text] [Related]
15. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype.
Albino AP; Sozzi G; Nanus DM; Jhanwar SC; Houghton AN
Oncogene; 1992 Nov; 7(11):2315-21. PubMed ID: 1437153
[TBL] [Abstract][Full Text] [Related]
17. Defining the mechanisms of transformation through analysis of revertant cells.
Bassin RH; Benade LE
Immunol Ser; 1990; 51():15-47. PubMed ID: 2095917
[No Abstract] [Full Text] [Related]
18. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines.
Bloethner S; Chen B; Hemminki K; Müller-Berghaus J; Ugurel S; Schadendorf D; Kumar R
Carcinogenesis; 2005 Jul; 26(7):1224-32. PubMed ID: 15760917
[TBL] [Abstract][Full Text] [Related]
19. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
[TBL] [Abstract][Full Text] [Related]
20. Severely decreased MARCKS expression correlates with ras reversion but not with mitogenic responsiveness.
Wojtaszek PA; Stumpo DJ; Blackshear PJ; Macara IG
Oncogene; 1993 Mar; 8(3):755-60. PubMed ID: 8437859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
